The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders. Alabama, Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington and West Virginia will use the grants to assess state needs, recruit and train providers, and improve reimbursement to expand treatment capacity. Section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorized the planning grants for a demonstration project to increase Medicaid provider capacity to treat SUDs. CMS will select up to five of the states to receive an enhanced federal matching rate for SUD services for three years under the project.

Headline
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
The Department of Health and Human Services Office for Civil Rights Feb. 13 announced the launch of a program to implement and enforce statutory and regulatory…
Headline
The AHA Feb. 17 submitted a comment letter responding to the Centers for Medicare & Medicaid Services’ proposed rule that would prohibit hospitals…
Headline
The Centers for Medicare & Medicaid Services Feb. 2 updated guidance originally issued in September on a budget reconciliation bill …
Headline
The White House issued an executive order Jan. 29 to address substance use and addiction. The order establishes the White House Great American Recovery…
Headline
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based provider tax, as authorized under…